The effect of prostaglandin inhibition on sodium excretion during expansion of the extracellular fluid volume.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D004285:Dogs; D005110:Extracellular Space / Q000502:physiology*; D005919:Glomerular Filtration Rate; D007213:Indomethacin / Q000494:pharmacology; D007263:Infusions, Parenteral; D007668:Kidney / Q000098:blood supply; D007677:Kidney Function Tests; D008469:Meclofenamic Acid / Q000494:pharmacology; D011448:Prostaglandin Antagonists / Q000494:pharmacology*; D011458:Prostaglandins E / Q000097:blood; D012039:Regional Blood Flow / Q000187:drug effects; D012964:Sodium / Q000652:urine*
D011448:Prostaglandin Antagonists; D011458:Prostaglandins E; D000804:Angiotensin II; D008469:Meclofenamic Acid; D012964:Sodium; D007213:Indomethacin